Brenus Pharma’s Revolutionary Colorectal Cancer Vaccine Launches in Human Trial
Lyon, France-based biotech company Brenus Pharma has announced the study design of “BreAK-CRC,” a first-in-human trial of its lead...
Lyon, France-based biotech company Brenus Pharma has announced the study design of “BreAK-CRC,” a first-in-human trial of its lead...
Medable, a leading provider of clinical trial technology, has once again secured the “Best Digital Health Solution” award at...
The union of Vector Laboratories and Absolute Biotech, facilitated by Thompson Street Capital Partners, is a strategic move that...
Positive Results from CatalYm’s GDFATHER Trial CatalYm’s “GDFATHER” Phase 1/2a trial has shown promising results for its lead candidate,...
Obsidian Therapeutics presented updated data from the Phase 1 study of OBX-115, an engineered tumor-derived autologous T-cell immunotherapy, at...
The European Committee for Medicinal Products for Human Use (CHMP) has granted a positive opinion for LIVMARLI (maralixibat) oral...
Fulgent Pharma, a subsidiary of Fulgent Genetics, will present Phase 1 clinical data on FID-007, its lead therapeutic candidate...
Beaconcure Inc., a leader in AI-driven clinical data validation, and Phastar Inc., a biometrics CRO, have partnered to streamline...
Accenture Ventures, the venture capital arm of Accenture, has invested in Turbine, a predictive simulation company developing a platform...
Alpha Cognition Inc., a biopharmaceutical company focused on neurodegenerative disorders, has shared its financial results and updated it for...